Completed PHASE1 INTERVENTIONAL 4-arm NCT00988585

Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched Oil (EPA)

Sponsor: Cardiovascular Research Associates

Interventions DHA EPA 1800 EPA 600 Olive Oil

Updated 5 times since 2017 Last updated: Jun 22, 2011 Started: Apr 30, 2009 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Heart Disease, this trial is completed. The trial is conducted by Cardiovascular Research Associates and has accumulated 5 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cardiovascular Research Associates
Dupont Applied Biosciences

Data source: Cardiovascular Research Associates

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States